Anagrelide Capsule
Product Images NDC 62135-312

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Anagrelide (NDC 62135-312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Anagrelide Capsules 120cap Bottle Label)

Image Description (Anagrelide Capsules 120cap Bottle Label)
Anagrelide 0.5 mg capsules label showing the product as a platelet-reducing agent. The label indicates it is an oral prescription drug, containing 120 capsules per bottle, manufactured by Chartwell RX, LLC. The label includes dosage, ingredient, and storage information along with a barcode and NDC number 62135-312-12.*
FDA Label Image

Image Description (Anagrelide Capsules 60cap Bottle Label)

Image Description (Anagrelide Capsules 60cap Bottle Label)
Label for Anagrelide Capsules, USP 1 mg by Chartwell RX, LLC. The label states it is a platelet-reducing agent, prescription only, and contains 60 capsules. The label includes storage instructions, ingredients, and a barcode with the NDC 62135-313-60.*
FDA Label Image

Image Description (Anagrelide Capsules Graph 1)

Image Description (Anagrelide Capsules Graph 1)
A line graph showing mean platelet count (x 10^3/µL) over time in weeks during Anagrelide therapy in patients with thrombocytosis secondary to myeloproliferative disorders. The graph shows a decreasing trend in platelet count from approximately 1200 at week 0 to around 500-600 by week 208. The number of subjects in assay decreases over time, noted below the x-axis.*
FDA Label Image

Image Description (Anagrelide Capsules Structure)

Image Description (Anagrelide Capsules Structure)
Chemical structure of the active ingredient anagrelide dihydrochloride monohydrate, showing a chlorinated fused ring system with nitrogen heteroatoms and a lactam moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.